Financial results - PIPERA PHARMA S.R.L.

Financial Summary - Pipera Pharma S.r.l.
Unique identification code: 27290534
Registration number: J51/171/2018
Nace: 4773
Sales - Ron
64.156
Net Profit - Ron
1.072
Employees
1
Open Account
Company Pipera Pharma S.r.l. with Fiscal Code 27290534 recorded a turnover of 2024 of 64.156, with a net profit of 1.072 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pipera Pharma S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 - - 0 15.236 44.646 46.858 49.047 66.228 64.156
Total Income - EUR 0 - - 0 15.236 44.735 46.882 49.049 66.257 64.213
Total Expenses - EUR 128 - - 1.790 19.183 36.948 38.777 62.240 59.827 62.906
Gross Profit/Loss - EUR -128 - - -1.790 -3.948 7.788 8.104 -13.192 6.429 1.307
Net Profit/Loss - EUR -128 - - -1.790 -4.380 6.480 6.698 -14.675 5.401 1.072
Employees 0 - - 0 1 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -2.6%, from 66.228 euro in the year 2023, to 64.156 euro in 2024. The Net Profit decreased by -4.299 euro, from 5.401 euro in 2023, to 1.072 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pipera Pharma S.r.l.

Rating financiar

Financial Rating -
PIPERA PHARMA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pipera Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pipera Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pipera Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pipera Pharma S.r.l. - CUI 27290534

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 335 - - 1.002 844 692 544 413 301 299
Current Assets 21.865 - - 20.939 25.781 32.397 40.837 22.826 27.788 18.458
Inventories 16.832 - - 17.830 19.627 21.650 28.421 13.192 16.975 9.609
Receivables 3.489 - - 3.068 5.144 6.098 6.907 5.016 7.922 3.472
Cash 1.544 - - 41 1.010 4.649 5.509 4.619 2.891 5.377
Shareholders Funds -32.536 - - -32.869 -36.612 -29.438 -22.087 -36.831 -31.318 -30.072
Social Capital 45 - - 43 42 41 40 41 40 40
Debts 54.736 - - 54.810 63.237 62.528 63.468 60.070 59.407 48.830
Income in Advance 0 - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 18.458 euro in 2024 which includes Inventories of 9.609 euro, Receivables of 3.472 euro and cash availability of 5.377 euro.
The company's Equity was valued at -30.072 euro, while total Liabilities amounted to 48.830 euro. Equity increased by 1.071 euro, from -31.318 euro in 2023, to -30.072 in 2024.

Risk Reports Prices

Reviews - Pipera Pharma S.r.l.

Comments - Pipera Pharma S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.